Active, Not Recruiting Lenvatinib and Everolimus in Treating Patients With Advanced, Unresectable Carcinoid Tumors NCT03950609 Conditions Advanced Carcinoid Tumor, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Digestive System Neuroendocrine Neoplasm, +16 more Locations M D Anderson Cancer Center — Houston, Texas, United States View Trial Details
